Latest NewsFDA NewsAdverse Event ManagementSupportive CareDisparities in Cancer CareDrug SafetyRadiation OncologySurvivorship Practice ManagementPreventionContributorsSponsored
Expert ConnectionsMorning RoundsThe VitalsPodcastsVideosBetween the LinesFrom All AnglesMeeting of the MindsTraining Academy
Conference CoverageConference Listing
Publications
Continuing Education
Case-Based Digest Rx Road MapEvents
SubscribePartners
Brain Cancer
Breast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head and Neck Cancers
HematologyHematologyHematologyHematologyHematologyHematology
Lung Cancer
Pediatric Cancer
Sarcomas
Skin CancerSkin Cancer
Advanced Practice Corner Logo
    Brain Cancer
    Breast CancerBreast Cancer
    Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
    Genitourinary CancerGenitourinary CancerGenitourinary CancerGenitourinary Cancer
    Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
    Head and Neck Cancers
    HematologyHematologyHematologyHematologyHematologyHematology
    Lung Cancer
    Pediatric Cancer
    Sarcomas
    Skin CancerSkin Cancer
    Advanced Practice Corner Logo
        • Publications
        • Subscribe
        • Partners
      Advertisement

      Cancer-Related Cognitive Impairment Affects Survivors' Daily Living

      July 2, 2019
      By AnnaLynn Williams, PhD
      Video

      Cancer-related cognitive impairments affect many survivors of the disease, and can have major impacts on their daily living.

      Cancer-related cognitive impairment can have a major impact on survivors' daily lives, and it is estimated that this malady impacts 30% to 70% of patients during or after cancer, explained AnnaLynn Williams, PhD, a postdoctoral research fellow at St. Jude Children's Research Hospital.

      TRANSCRIPTION

      Cancer-related cognitive impairment is a really significant issue for our cancer patients. We estimate that it affects anywhere from 30 to 70% of patients, both during and after treatment. Patients often experience problem with memory or paying attention, being able to focus, and really completing daily tasks. We know that if they have issues with cognitive impairment, it affects their quality of life, it might affect their ability to read or drive, their ability to connect socially, and most importantly their ability to return to work or school if they are younger patients.

      Newsletter

      Stay up to date on recent advances in oncology nursing and patient care.

      Subscribe Now!
      Recent Videos
      Photo of a woman with brown hair and bangs
      Photo of a man wearing a suit in front of an Oncology Nursing News backdrop
      Related Content

      Photo of a woman with brown hair and bangs, surrounded by a blue border

      AE Education Aids Breast Cancer Decisions, Says Survivorship Expert

      Michelle Kirschner, RN, MSN, ACNP, APRN-BC
      September 16th 2025
      Article

      Oncology Nursing Stories: Acupuncture Helps Thyroid Cancer Survivor Taper Opioid Use

      Oncology Nursing Stories: Acupuncture Helps Thyroid Cancer Survivor Taper Opioid Use

      Lindsay Fischer
      September 16th 2025
      Podcast

      Person acute kidney injury Comprehensive image overview of kidneys showing sudden loss of function | Image Credit: © Premium Graphics - stock.adobe.com.

      Opinion: Novel Risk Assessment Tool Helps Predict Cisplatin-Induced Acute Kidney Injury

      Amanda Brink, DNP, APRN, FNP-BC, AOCNP
      September 16th 2025
      Article

      Nursing Perspectives on Managing Toxicities With ADCs in Metastatic Gastric and Breast Cancers

      Nursing Perspectives on Managing Toxicities With ADCs in Metastatic Gastric and Breast Cancers

      Lindsay Fischer
      September 16th 2025
      Podcast

      Cisplatin-Based Chemotherapy May Affect Hearing in Cancer Survivors

      Cisplatin-Based Chemotherapy May Affect Hearing in Cancer Survivors

      Roman Fabbricatore
      September 16th 2025
      Article

      Hearing loss concept. Woman and sound waves illustration on light blue background, closeup: © New Africa - stock.adobe.com

      Increasing Awareness of Audiovestibular Adverse Events From Immune Checkpoint Inhibitors

      Iryna Singh, NP
      September 16th 2025
      Article
      Related Content

      Photo of a woman with brown hair and bangs, surrounded by a blue border

      AE Education Aids Breast Cancer Decisions, Says Survivorship Expert

      Michelle Kirschner, RN, MSN, ACNP, APRN-BC
      September 16th 2025
      Article

      Oncology Nursing Stories: Acupuncture Helps Thyroid Cancer Survivor Taper Opioid Use

      Oncology Nursing Stories: Acupuncture Helps Thyroid Cancer Survivor Taper Opioid Use

      Lindsay Fischer
      September 16th 2025
      Podcast

      Person acute kidney injury Comprehensive image overview of kidneys showing sudden loss of function | Image Credit: © Premium Graphics - stock.adobe.com.

      Opinion: Novel Risk Assessment Tool Helps Predict Cisplatin-Induced Acute Kidney Injury

      Amanda Brink, DNP, APRN, FNP-BC, AOCNP
      September 16th 2025
      Article

      Nursing Perspectives on Managing Toxicities With ADCs in Metastatic Gastric and Breast Cancers

      Nursing Perspectives on Managing Toxicities With ADCs in Metastatic Gastric and Breast Cancers

      Lindsay Fischer
      September 16th 2025
      Podcast

      Cisplatin-Based Chemotherapy May Affect Hearing in Cancer Survivors

      Cisplatin-Based Chemotherapy May Affect Hearing in Cancer Survivors

      Roman Fabbricatore
      September 16th 2025
      Article

      Hearing loss concept. Woman and sound waves illustration on light blue background, closeup: © New Africa - stock.adobe.com

      Increasing Awareness of Audiovestibular Adverse Events From Immune Checkpoint Inhibitors

      Iryna Singh, NP
      September 16th 2025
      Article

      Latest Conference Coverage

      Nurses Lead Toxicity Monitoring in Indolent Lymphoma Care

      Osimertinib/Chemo Boosts Survival in Frontline EGFR+ NSCLC

      Lutetium Lu 177 Dotatate Brings Partial Response in Metastatic BP-NETs

      Safety Management With Amivantamab Plus Lazertinib in NSCLC

      View More Latest Conference Coverage
      About Us
      Editorial Board
      Contact Us
      CancerNetwork.com
      CureToday.com
      OncLive.com
      TargetedOnc.com
      Advertise
      Privacy
      Terms & Conditions
      Do Not Sell My Information
      Contact Info

      259 Prospect Plains Rd, Bldg H,
      Monroe, NJ 08831

      609-716-7777

      © 2025 MJH Life Sciences

      All rights reserved.